Attila Pethö‐Schramm

1.1k total citations
34 papers, 658 citations indexed

About

Attila Pethö‐Schramm is a scholar working on Rheumatology, Genetics and Hematology. According to data from OpenAlex, Attila Pethö‐Schramm has authored 34 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 8 papers in Genetics and 7 papers in Hematology. Recurrent topics in Attila Pethö‐Schramm's work include Rheumatoid Arthritis Research and Therapies (23 papers), Systemic Lupus Erythematosus Research (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Attila Pethö‐Schramm is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (23 papers), Systemic Lupus Erythematosus Research (10 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Attila Pethö‐Schramm collaborates with scholars based in Switzerland, Netherlands and United States. Attila Pethö‐Schramm's co-authors include Hans‐Joachim Müller, Christoph Brunner, Marion Helmhold, Victor W. Armstrong, Francesco Paolo Mancini, Gerd Utermann, Rudy Guerra, Vincent Mooser, Helen H. Hobbs and Eric Boerwinkle and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The FASEB Journal.

In The Last Decade

Attila Pethö‐Schramm

33 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Attila Pethö‐Schramm Switzerland	12	249	217	192	115	96	34	658
Irmgard Andresen Germany	15	189 0.8×	131 0.6×	169 0.9×	60 0.5×	214 2.2×	41	852
Sophie J. Bernelot Moens Netherlands	16	301 1.2×	74 0.3×	194 1.0×	98 0.9×	212 2.2×	23	823
Tsukasa Teramoto Japan	14	436 1.8×	88 0.4×	150 0.8×	88 0.8×	55 0.6×	70	757
Natasha Barascuk Denmark	15	99 0.4×	136 0.6×	215 1.1×	143 1.2×	76 0.8×	20	766
Raphaël Thuillet France	17	177 0.7×	103 0.5×	318 1.7×	93 0.8×	180 1.9×	42	1.3k
Ugochukwu C. Nzeako United States	14	195 0.8×	180 0.8×	144 0.8×	108 0.9×	116 1.2×	19	1.1k
Mingguo Huang Japan	20	76 0.3×	221 1.0×	433 2.3×	254 2.2×	288 3.0×	51	1.1k
Lichen Teng China	17	79 0.3×	371 1.7×	270 1.4×	156 1.4×	299 3.1×	63	1.0k
Yassamin Feroz Zada Canada	10	81 0.3×	47 0.2×	190 1.0×	101 0.9×	90 0.9×	17	680
Emma Guagnellini Italy	12	99 0.4×	69 0.3×	186 1.0×	332 2.9×	73 0.8×	21	693

Countries citing papers authored by Attila Pethö‐Schramm

Since Specialization

Citations

This map shows the geographic impact of Attila Pethö‐Schramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attila Pethö‐Schramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attila Pethö‐Schramm more than expected).

Fields of papers citing papers by Attila Pethö‐Schramm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attila Pethö‐Schramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attila Pethö‐Schramm. The network helps show where Attila Pethö‐Schramm may publish in the future.

Co-authorship network of co-authors of Attila Pethö‐Schramm

This figure shows the co-authorship network connecting the top 25 collaborators of Attila Pethö‐Schramm. A scholar is included among the top collaborators of Attila Pethö‐Schramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attila Pethö‐Schramm. Attila Pethö‐Schramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paul, Sanjoy K., Olga Montvida, Jennie H. Best, et al.. (2021). Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis. BMJ Open. 11(6). e042246–e042246. 3 indexed citations

Curtis, Jeffrey R., Christine de la Loge, Benoît Arnould, et al.. (2021). Development and validation of the Methotrexate Experience Questionnaire, a new methotrexate oral treatment adherence tool in rheumatoid arthritis. Journal of Patient-Reported Outcomes. 5(1). 69–69. 3 indexed citations

Teitsma, Xavier M, Jenny Devenport, Johannes W. G. Jacobs, et al.. (2020). Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab. PLoS ONE. 15(12). e0241189–e0241189. 3 indexed citations

Tekstra, Janneke, Jacob M. van Laar, Attila Pethö‐Schramm, et al.. (2020). Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis. The Journal of Rheumatology. 48(4). 495–503. 4 indexed citations

Teitsma, Xavier M, Wei Yang, Johannes W. G. Jacobs, et al.. (2018). Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology. Arthritis Research & Therapy. 20(1). 230–230. 29 indexed citations

Teitsma, Xavier M, Johannes W. G. Jacobs, Paco M J Welsing, et al.. (2018). Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors. Annals of the Rheumatic Diseases. 77(9). 1261–1267. 32 indexed citations

Choy, Ernest, Roberto Caporali, Ricardo Machado Xavier, et al.. (2018). Effects of concomitant glucocorticoids in TOZURA, a common-framework study programme of subcutaneous tocilizumab in rheumatoid arthritis. Lara D. Veeken. 58(6). 1056–1064. 9 indexed citations

Teitsma, Xavier M, Johannes W. G. Jacobs, Paco M J Welsing, et al.. (2017). Patient-reported outcomes in newly diagnosed early rheumatoid arthritis patients treated to target with a tocilizumab- or methotrexate-based strategy. Lara D. Veeken. 56(12). 2179–2189. 6 indexed citations

Pethö‐Schramm, Attila, et al.. (2017). OP0293 Weighted gene co-expression network analysis of DMARD-NAÏVE early ra patients achieving sustained drug-free remission after initiating tocilizumab therapy. Annals of the Rheumatic Diseases. 76. 177–178. 1 indexed citations

10.

Pethö‐Schramm, Attila, et al.. (2017). SAT0218 Effect of tocilizumab in DMARD-NAÏVE early rheumatoid arthritis patients on health-related quality of life: results of the U-ACT-EARLY trial. Annals of the Rheumatic Diseases. 76. 855–855. 2 indexed citations

11.

Teitsma, Xavier M, Johannes W. G. Jacobs, Michal Mokrý, et al.. (2017). Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy. Arthritis Research & Therapy. 19(1). 170–170. 14 indexed citations

12.

Teitsma, Xavier M, Johannes W. G. Jacobs, Paco M J Welsing, et al.. (2017). Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies. Lara D. Veeken. 57(2). 309–317. 14 indexed citations

13.

Choy, Ernest, Roberto Caporali, Ricardo Machado Xavier, et al.. (2016). FRI0215 Subcutaneous Tocilizumab as Monotherapy or in Combination with A csDMARDs in Patients with Rheumatoid Arthritis – Interim Analysis of A Large Phase IV International Umbrella Study, “Tozura”. Annals of the Rheumatic Diseases. 75. 509–510. 4 indexed citations

14.

Pethö‐Schramm, Attila, et al.. (1996). FGF5 and the murine hair cycle. Archives of Dermatological Research. 288(5-6). 264–266. 25 indexed citations

15.

Brunner, Christoph, Attila Pethö‐Schramm, Chantal Kang, et al.. (1996). The Number of Identical Kringle IV Repeats in Apolipoprotein(a) Affects Its Processing and Secretion by HepG2 Cells. Journal of Biological Chemistry. 271(50). 32403–32410. 83 indexed citations

16.

Mooser, Vincent, Francesco Paolo Mancini, Attila Pethö‐Schramm, et al.. (1995). Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Human Molecular Genetics. 4(2). 173–181. 110 indexed citations

17.

Helmhold, Marion, et al.. (1995). Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32−36 of Human Apolipoprotein(a). Journal of Biological Chemistry. 270(11). 6227–6234. 87 indexed citations

18.

Vetterlein, F., et al.. (1994). Reconstruction of Blood Flow Distribution in the Rat Kidney during Postischemic Renal Failure. The Nephron journals/Nephron journals. 66(2). 208–214. 4 indexed citations

19.

Vetterlein, F., et al.. (1991). Increased accumulation of plasma albumin in the extracellular space of the heart during hypoxia.. PubMed. 10(3). 183–92. 3 indexed citations

20.

Pethö‐Schramm, Attila, et al.. (1991). Effects of diltiazem and allopurinol in postischemic microcirculatory changes in the rat kidney.. PubMed. 10(2). 155–68. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact